China Meheco Co Ltd (SHG:600056) — Market Cap & Net Worth
Market Cap & Net Worth: China Meheco Co Ltd (600056)
China Meheco Co Ltd (SHG:600056) has a market capitalization of $1.98 Billion (CN¥13.54 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #6259 globally and #1232 in its home market, demonstrating a 0.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying China Meheco Co Ltd's stock price CN¥9.05 by its total outstanding shares 1495879748 (1.50 Billion). Also see how large is China Meheco Co Ltd's balance sheet for a full breakdown of the balance sheet.
China Meheco Co Ltd Market Cap History: 2015 to 2026
China Meheco Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.25 Billion to $1.98 Billion (-0.54% CAGR). Also see how efficiently does China Meheco Co Ltd generate cash for how efficiently the company converts equity into cash flow.
China Meheco Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how China Meheco Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 600056 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
China Meheco Co Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.78x
China Meheco Co Ltd's market cap is 4.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.61 Billion | $25.95 Billion | $949.69 Million | 0.10x | 2.74x |
| 2017 | $3.44 Billion | $30.36 Billion | $1.31 Billion | 0.11x | 2.62x |
| 2018 | $1.77 Billion | $31.01 Billion | $1.54 Billion | 0.06x | 1.15x |
| 2019 | $1.90 Billion | $35.28 Billion | $981.35 Million | 0.05x | 1.94x |
| 2020 | $2.13 Billion | $39.31 Billion | $1.31 Billion | 0.05x | 1.62x |
| 2021 | $1.80 Billion | $36.23 Billion | $647.06 Million | 0.05x | 2.79x |
| 2022 | $3.73 Billion | $37.59 Billion | $735.60 Million | 0.10x | 5.07x |
| 2023 | $2.45 Billion | $38.82 Billion | $1.05 Billion | 0.06x | 2.33x |
| 2024 | $2.43 Billion | $34.15 Billion | $535.47 Million | 0.07x | 4.54x |
| 2025 | $2.26 Billion | $35.36 Billion | $473.23 Million | 0.06x | 4.78x |
Competitor Companies of 600056 by Market Capitalization
Companies near China Meheco Co Ltd in the global market cap rankings as of September 24, 2026. Review China Meheco Co Ltd (600056) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to China Meheco Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #252 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #548 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #647 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1243 globally with a market cap of $20.91 Billion USD ( AU$29.55 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #252 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $891.23 |
| #548 | Cencora Inc. | NYSE:COR | $50.53 Billion | $314.43 |
| #647 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $222.04 |
| #1243 | Sigma Healthcare Ltd | AU:SIG | $20.91 Billion | AU$2.56 |
China Meheco Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, China Meheco Co Ltd's market cap moved from $2.25 Billion to $ 1.98 Billion, with a yearly change of -0.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.98 Billion | -12.39% |
| 2025 | CN¥2.26 Billion | -6.94% |
| 2024 | CN¥2.43 Billion | -0.63% |
| 2023 | CN¥2.45 Billion | -34.43% |
| 2022 | CN¥3.73 Billion | +106.71% |
| 2021 | CN¥1.80 Billion | -15.14% |
| 2020 | CN¥2.13 Billion | +11.94% |
| 2019 | CN¥1.90 Billion | +7.19% |
| 2018 | CN¥1.77 Billion | -48.57% |
| 2017 | CN¥3.44 Billion | +32.15% |
| 2016 | CN¥2.61 Billion | +15.83% |
| 2015 | CN¥2.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of China Meheco Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.98 Billion USD |
| MoneyControl | $1.98 Billion USD |
| MarketWatch | $1.98 Billion USD |
| marketcap.company | $1.98 Billion USD |
| Reuters | $1.98 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About China Meheco Co Ltd
China Meheco Group Co., Ltd. operates in pharmaceutical industry in China and internationally. The company is involved in international trade of pharmaceuticals, including pharmaceutical preparations, drug substances, intermediates, medical devices, medical consumables, Chinese medicinal materials, and extracts; and pharmaceutical commerce business. It also provides supply chain services, such as… Read more